Iktos
Laboratory & Pharmaceutical Robotics · Drug Discovery AI
People
Roman Fleck
Président du conseil d’administration
Yann Gaston-Mathe Gaston
Directeur Général
Yann Gaston-Mathé
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
M VenturesVia a fund
Omnes CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Iktos Enters Strategic €1B+ Multi-Target AI Partnership with Servier to Advance Drug Discovery in Oncology and Neurology
Read more
Report
Iktos Enters Strategic €1B+ Multi-Target AI Partnership with Servier to Advance Drug Discovery in Oncology and Neurology
Read more
Report
Now Iktos teams up with Pierre Fabre in oncology
As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos
Read more
Report
Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration
/PRNewswire/ -- Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and...
Read more
Report
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery
PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an exclusive worldwide license to INSERM's patented technology enab
Read more
Report
Correction: Kissei introduces Iktos AI Drug Discovery System
Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 - Iktos, a company specialized in Artificial Intelligence for new drug design, today announced that Kissei Pharmaceutical Co., Ltd. (
Read more
Report
Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design
Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives with innovative peptide-based medicines to co-develop generative and pred
Read more
Report
Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design
Read more
Report
Iktos and Astrogen Announce a Research Collaboration to Use Artificial Intelligence Platform for Drug Design against a Novel Parkinson's Disease Target
Read more
Report
Iktos and The University of Dundee, Drug Discovery Unit (DDU) Announce a Collaboration to Use AI for Drug Design and Retrosyntheis
Iktos, a company specialized in Artificial Intelligence for new drug design, and The Drug Discovery Unit (DDU), School of Life Sciences, The University of Dundee, focused on the discovery of therapeutics
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
Iktos Engine: APIs for Agentic workflows and Computational Chemistry Pipelines